Growth Metrics

Akebia Therapeutics (AKBA) Other Working Capital Changes (2016 - 2026)

Akebia Therapeutics has reported Other Working Capital Changes over the past 10 years, most recently at $3.9 million for Q4 2025.

  • Quarterly Other Working Capital Changes rose 230.31% to $3.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$112000.0 through Dec 2025, up 98.19% year-over-year, with the annual reading at -$112000.0 for FY2025, 98.19% up from the prior year.
  • Other Working Capital Changes was $3.9 million for Q4 2025 at Akebia Therapeutics, up from -$9.5 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $17.1 million in Q4 2022 and troughed at -$10.5 million in Q3 2023.
  • The 5-year median for Other Working Capital Changes is -$1.5 million (2023), against an average of -$780944.4.
  • Year-over-year, Other Working Capital Changes soared 2538.43% in 2022 and then crashed 661.61% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $648000.0 in 2021, then soared by 2538.43% to $17.1 million in 2022, then tumbled by 110.5% to -$1.8 million in 2023, then crashed by 66.59% to -$3.0 million in 2024, then soared by 230.31% to $3.9 million in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Other Working Capital Changes are $3.9 million (Q4 2025), -$9.5 million (Q3 2025), and $5.2 million (Q2 2025).